You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TILs

Showing 1 - 25 of 307
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

Metastatic Triple-Negative Breast Carcinoma Trial in Barcelona, Madrid, Pamplona (PD1+ TILs (NUMARZU-001) product infusion)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • PD1+ TILs (NUMARZU-001) product infusion
  • Barcelona, Spain
  • +3 more
Jul 8, 2022

Glioblastoma Multiforme, Adult Trial in Shijiazhuang (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioblastoma Multiforme, Adult
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shijiazhuang, Hebei, China
    The Second Hospital of HeBei Medical University
Apr 11, 2022

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial in Tianjin (LM103)

Recruiting
  • Solid Tumor
  • LM103
  • Tianjin, China
    Tianjin Beichen Hospital
Jul 4, 2023

Breast Cancer, Triple-Negative Breast Cancer Trial in Guangzhou, Nanjing, Shanghai (Anti-PD-1 mAb, VEGFR2 Tyrosine Kinase

Recruiting
  • Breast Cancer
  • Triple-Negative Breast Cancer
  • Anti-PD-1 monoclonal antibody
  • VEGFR2 Tyrosine Kinase Inhibitor
  • Guangzhou, Guangdong, China
  • +2 more
Sep 24, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Post-traumatic Stress Disorder (PTSD) Trial in Arlington (TILS, sham)

Terminated
Has Results
  • Post-traumatic Stress Disorder (PTSD)
  • TILS
  • sham
  • Arlington, Texas
    Engineering Research Building (ERB), University of Texas Arlingt
Jun 30, 2021

NSCLC Trial (TILs(Tumor Infiltrating Lymphocytes))

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • TILs（Tumor Infiltrating Lymphocytes）
  • (no location specified)
Jun 2, 2021

Liver Cancer, Lung Cancer, Breast Cancer Trial in Guangzhou (TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y,

Recruiting
  • Liver Cancer
  • +7 more
  • TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3
  • Guangzhou, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 9, 2021

Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma Trial in Tianjin (Autologous tumor infiltrating lymphocytes (TILs))

Recruiting
  • Melanoma
  • +2 more
  • Autologous tumor infiltrating lymphocytes (TILs)
  • Tianjin, China
    Tianjin Beichen Hospital
Aug 1, 2022

Tumor Infiltrating Lymphocytes Trial (Autologous tumor-infiltrating lymphocytes)

Not yet recruiting
  • Tumor Infiltrating Lymphocytes
  • Autologous tumor-infiltrating lymphocytes
  • (no location specified)
Nov 28, 2021

Solid Tumor, Adult, Cervical Cancer, Sarcoma Trial in Shijiazhuang (Autologous aPD-L1 armored anti-CD22 CAR T cells)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Autologous aPD-L1 armored anti-CD22 CAR T cells
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
May 25, 2021

Soft Tissue Sarcoma Trial in Copenhagen (LTX-315 and TILs)

Active, not recruiting
  • Soft Tissue Sarcoma
  • LTX-315 and TILs
  • Copenhagen, Denmark
    Herlev Hospital
Aug 27, 2021

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Hepatic Carcinoma Trial in Shanghai (Tumor infiltrating lymphocyte)

Unknown status
  • Hepatic Carcinoma
  • Tumor infiltrating lymphocyte
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital
Aug 28, 2020

Metastatic Ovarian Cancer Trial in Copenhagen (Cyclophosphamide, Fludarabine, TIL infusion)

Completed
Has Results
  • Metastatic Ovarian Cancer
  • Copenhagen, Denmark
    Center for Cancer Immune Therapy Dept. of Hematology/oncology
Feb 25, 2021

Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,

Recruiting
  • Metastatic Ovarian Cancer
  • +2 more
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Non Small Cell Lung Cancer Trial in Durham (Ipilimumab, Paclitaxel, Cisplatin, Carboplatin)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
Feb 24, 2021

Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumor
  • Tumor Infiltrating Lymphocytes
  • +3 more
  • (no location specified)
Dec 11, 2022

Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)

Completed
  • Advanced Ovarian Cancer
  • Malignant Melanoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Aug 12, 2020

Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

Not yet recruiting
  • Advanced Breast Cancer
  • Advanced Lung Cancer
  • Tumor-infiltrating lymphocytes
  • IL-2
  • (no location specified)
Oct 26, 2023